Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8186461rdf:typepubmed:Citationlld:pubmed
pubmed-article:8186461lifeskim:mentionsumls-concept:C0079460lld:lifeskim
pubmed-article:8186461lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:8186461lifeskim:mentionsumls-concept:C0054450lld:lifeskim
pubmed-article:8186461lifeskim:mentionsumls-concept:C0024297lld:lifeskim
pubmed-article:8186461lifeskim:mentionsumls-concept:C1333104lld:lifeskim
pubmed-article:8186461lifeskim:mentionsumls-concept:C0013879lld:lifeskim
pubmed-article:8186461lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:8186461lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:8186461pubmed:issue1lld:pubmed
pubmed-article:8186461pubmed:dateCreated1994-6-20lld:pubmed
pubmed-article:8186461pubmed:abstractTextGranulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-2 (IL-2) are produced by stimulation with phorbol-12-myristate acetate (PMA) and calcium ionophore (A23187) in human T cell leukemia Jurkat cells. The expression of GM-CSF and IL-2 is inhibited by immunosuppressive drugs such as cyclosporin A (CsA) and FK506. Earlier studies on the IL-2 gene expression showed that overexpression of calcineurin (CN), a Ca2+/calmodulin-dependent protein phosphatase, can stimulate transcription from the IL-2 promoter through the NF-AT-binding site. In this study, we obtained evidence that transfection of the cDNAs for CN A (catalytic) and CN B (regulatory) subunits also augments transcription from the GM-CSF promoter and recovers the transcription inhibited by CsA. The constitutively active type of the CN A subunit, which lacks the auto-inhibitory and calmodulin-binding domains, acts in synergy with PMA to activate transcription from the GM-CSF promoter. We also found that the active CN partially replaces calcium ionophore in synergy with PMA to induce expression of endogenous GM-CSF and IL-2. By multimerizing the regulatory elements of the GM-CSF promoter, we found that one of the target sites for the CN action is the conserved lymphokine element 0 (CLE0), located at positions between -54 and -40. Mobility shift assays showed that the CLE0 sequence has an AP1-binding site and is associated with an NF-AT-like factor, termed NF-CLE0 gamma. NF-CLE0 gamma binding is induced by PMA/A23187 and is inhibited by treatment with CsA. These results suggest that CN is involved in the coordinated induction of the GM-CSF and IL-2 genes and that the CLE0 sequence of the GM-CSF gene is a functional analogue of the NF-AT-binding site in the IL-2 promoter, which mediates signals downstream of T cell activation.lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:languageenglld:pubmed
pubmed-article:8186461pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:citationSubsetIMlld:pubmed
pubmed-article:8186461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8186461pubmed:statusMEDLINElld:pubmed
pubmed-article:8186461pubmed:monthJanlld:pubmed
pubmed-article:8186461pubmed:issn1059-1524lld:pubmed
pubmed-article:8186461pubmed:authorpubmed-author:NaitoYYlld:pubmed
pubmed-article:8186461pubmed:authorpubmed-author:AraiKKlld:pubmed
pubmed-article:8186461pubmed:authorpubmed-author:AraiNNlld:pubmed
pubmed-article:8186461pubmed:authorpubmed-author:TsuboiAAlld:pubmed
pubmed-article:8186461pubmed:authorpubmed-author:TokumitsuHHlld:pubmed
pubmed-article:8186461pubmed:authorpubmed-author:MasudaE SESlld:pubmed
pubmed-article:8186461pubmed:issnTypePrintlld:pubmed
pubmed-article:8186461pubmed:volume5lld:pubmed
pubmed-article:8186461pubmed:ownerNLMlld:pubmed
pubmed-article:8186461pubmed:authorsCompleteYlld:pubmed
pubmed-article:8186461pubmed:pagination119-28lld:pubmed
pubmed-article:8186461pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
pubmed-article:8186461pubmed:meshHeadingpubmed-meshheading:8186461-...lld:pubmed
More...